Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells

References

• Anderson, P., Yip, Y. K. & Vilcek, J. (1983). Human interferon-gamma is internalised and degraded by cultured fibroblasts. Journal of Biological Chemistry, 258, 6497–6502.
   PubMed Web of Science ®Google Scholar
• Auwerx, J. (1991). The human leukemia cell line THP1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia, 47, 22–31.
   PubMedGoogle Scholar
• Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., Bina, J. C., Teixeira, R., Falcoff, R., Rocha, H., Ho, J. L. & Johnson, W. D. (1990). Treatment of visceral leishmaniasis with pentavalent antimony and inter-feron gamma. New England Journal of Medicine, 322, 16–21.
   PubMed Web of Science ®Google Scholar
• Baer, H. P., Schmidt, K., Mayer, B. & Kukovetz, W. R. (1995). Pentamidine does not interfere with nitrite formation in activated RAW 264.7 macrophages but inhibits constitutive brain nitric oxide synthase. Life Sciences, 57, 1973–1980.
   PubMed Web of Science ®Google Scholar
• Bell, C. A., Cory, M., Fairley, T. A., Hall, J. E. & Tidwel, R. R. (1991). Structure—activity relationships of pentamidine analogs against Giardia lam blia and correlation of antigiardial activity with DNA-binding affinity. Antimicrobial Agents and Chemotherapy, 35, 1099–1107.
   PubMed Web of Science ®Google Scholar
• Bemabei, P., Allione, A., Rigamonti, L., Bosticardo, M., Losana, G., Borghi, I., Forni, G. & Novelli, F. (2001). Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. European Cytokine Network, 12, 6–14.
   PubMed Web of Science ®Google Scholar
• Berman, J. D. & Wyler, D. J. (1980). An in vitro model for investigation of chemotherapeutic agents in Leishmania. Journal of Infectious Diseases, 142, 83.
   PubMed Web of Science ®Google Scholar
• Berman, J. D., Edwards, N. & King, M. (1989). Biochemistry of Pentostam resistant Leishmania. American Journal of Tropical Medicine and Hygiene, 40, 159–164.
   PubMed Web of Science ®Google Scholar
• Bitonti, A. J., Dumant, J. A. & McCann, P. P. (1986). Characterization of Trypanosoma brucei brucei S-adenosyl L-methionine decarboxylase and its inhibition by berenil, pentamidine and methylglyoxal bis (Guanylhydrazone). Biochemical Journal, 237, 685–689.
   PubMed Web of Science ®Google Scholar
• Buates, S. & Matlashewski, G. (2001). General sup-pression of macrophage gene expression during Leishmania donovani infection. Journal of Immunology, 166, 3416–3422.
   PubMed Web of Science ®Google Scholar
• Carrera, L., Gazzinelli, R. T., Badolato, R., Hiney, S., Muller, W., Kuhu, R. & Sacks, D. L. (1996). Leishmania promastigotes selectively inhibit inter-leukin 12 induction in bone marrow-derived macro-phages from susceptible and resistant mice. Journal of Experimental Medicine, 183, 515–526.
   PubMed Web of Science ®Google Scholar
• Carter, N. S. & Fairlamb, A. H. (1993). Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature, 361, 173–176.
   PubMed Web of Science ®Google Scholar
• Celada, A. (1988). The interferon gamma receptor. Lymphokine Research, 7, 61–73.
   PubMedGoogle Scholar
• Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate—phenol—chloroform extraction. Analytical Biochemistry, 162, 156–159.
   PubMed Web of Science ®Google Scholar
• Croft, S. L. (2001) Monitoring drug resistance in leishmaniasis. Tropical Medicine and International Health, 6, 899–905.
   PubMed Web of Science ®Google Scholar
• Dellacasagrande, T., Capo, C., Raoult, D. & Mege, J. L. (1999). IFN-7 mediated control of Coxiella burnetti survival in monocytes: the role of cell apoptosis and TNF. Journal of Immunology, 162, 2259–2265.
   PubMed Web of Science ®Google Scholar
• Delmas, F., di Giorgio, C., Elias, R., Gasquet, M., Azas, N., Mshvildadze, V., Dekanosidze, G., Kemertelidze, E. & Timon-David, P. (2000). Antileishmanial activity of three saponins isolated from ivy, alpha-hederin and hederacolchiside Al, as com-pared to their action on mammalian cells cultured in vitro. Planta Medial, 66, 343–347.
   Google Scholar
• Ebensperger, C., Rhee, S., Muthumaran, G., Lembo, D., Donnelly, R., Pestka, S. & Dembic, Z. (1996). Genomic organization and promoter analysis of the gene ifngr2 encoding the second chain of the mouse interferon-7 receptor. Scandinavian Journal of Immunology, 44, 599–606.
   PubMed Web of Science ®Google Scholar
• Farrar, M. A., Fernandez-Luna, J. & Schreiber, R. D. (1999). Identification of two regions within the cyto-plasmic domain of the human interferon-gamma receptor required for function. Journal of Biological Chemistry, 266, 19,626-19,635.
   Google Scholar
• Garcia, R. C., Banfi, E. & Pittis, M. G. (2000). Infection of macrophage-like THP1 cells with Mycobacterium avium results in a decrease in their ability to phosphorylate nucleolin. Infection and Immunity, 68, 3121–3128.
   PubMed Web of Science ®Google Scholar
• Gebre-Hiwot, A., Tadesse, G., Croft, S. L. & Frommel, D. (1992). An in vitro model for screening antileishmanial drugs: the human leukemia cell line, THP1 . Acta Tropica, 51, 237–245.
   PubMed Web of Science ®Google Scholar
• Goodwin, J. G. & Page, J. E. (1943). Study of the excretion of organic antimonials using a polaro-graphic procedure. Biochemical Journal, 37, 198.
   PubMedGoogle Scholar
• Hokertz, S., Baccrani, M. & Lohmann-Mathes, M. L. (1989). Functional heterogeneity of macrophage pre-cursor cells from spleen of Leishmania donovani infected and uninfected mice. Journal of Immunology, 128, 2487–2494.
   Google Scholar
• Jha, T. K., Sundar, S., Thakur, C. P., Bachmann, P., Karbwang, J., Fischer, C., Voss, A. & Berman, J. (1999). Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. New England Journal of Medicine, 341, 1795–1800.
   PubMed Web of Science ®Google Scholar
• Luo, Z. D., Wang, Y., Werlen, G., Camp, S., Chien, K. R. & Taylor, P. (1999). Calcineurin enhances acetylcholine esterase mRNA stability during C2—C12 muscle cell differentiation. Molecular Pharmacology, 56, 886–894.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., Fritsch, E. F. & Sambrook, J. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Publications.
   Google Scholar
• Merlin, G., van der Leede, B.-J., Aguet, M. & Dembic, Z. (1989). The human interferon gamma receptor gene. Journal of Interferon Research, 9, 89.
   Google Scholar
• Mohamed, A. M., Taye, T. & Akuffo, H. O. (1992). Mechanisms of resistance to Leishmania aethiopica. Interferon-gamma in combination with a cytokine (not tumor necrosis factor alpha) is required, but cannot act alone in the inhibition of intracellular forms of L. aethiopica in THP1 cells. European Journal of Immunology, 22, 2331-2337.
   Google Scholar
• Oliver, M., Baimbridge, K. G. & Reiner, N. E. (1992). Stimulus-response coupling in monocytes infected with Leishmania: attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. Journal of Immunology, 148, 1188–1196.
   PubMed Web of Science ®Google Scholar
• Pfizenmaier, K., Wiegmann, K., Scheurich, P., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M. & Aguet, M. (1988). High affinity human IFN-gamma-binding capacity is encoded by a single receptor gene located in proximity to c-ras on human chromosome region 6q16 to 6q22. Journal of Immunology, 141, 856–860.
   PubMed Web of Science ®Google Scholar
• Ray, M., Gam, A. A., Boykins, R. A. & Kenny, R. T. (2000). Inhibition of interferon 7 signalling by Leishmania donovani. Journal of Infectious Diseases, 181, 1121–1128.
   PubMed Web of Science ®Google Scholar
• Roberts, W. L., Berman, J. D. & Rainey, P. M. (1995). In vitro antileishmanial properties of tri- and penta-valent antimonial preparations. Antimicrobial Agents and Chemotherapy, 39, 1234–1239.
   PubMed Web of Science ®Google Scholar
• Saha, A. K., Mukherjee, T. & Bhaduri, A. (1986). Mechanism of activation of amphotericin B on Leishmania donovani promastigotes. Molecular Biochemistry and Parasitology, 19, 195–200.
   PubMed Web of Science ®Google Scholar
• Saha, B., Roy, H. N., Pakrashi, A., Chakraborti, R. N. & Roy, S. (1991). Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis. European Journal of Immunology, 21, 577–581.
   PubMed Web of Science ®Google Scholar
• Saha, B., Bandopadhyay, D. & Roy, S. (1995). Immunobiological studies on experimental visceral leishmaniasis. IV. Kinetics of evolution of disease promoting versus host protective cells of monocyte-macrophage lineage and their characterization. Scandinavian Journal of Immunology, 42, 540–546.
   PubMed Web of Science ®Google Scholar
• Sands, M., Kron, M. A. & Brown, R. B. (1985). Pentamidine: a review. Reviews of Infectious Diseases, 7,625–634.
   PubMedGoogle Scholar
• Sereno, D., Holzmuller, P. & Lemesre, J. L. (2000). Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Tropica, 74,25–31.
   PubMed Web of Science ®Google Scholar
• Sereno, D., Holzmuller, P., Mangot, I., Cuny, G., Ovaissi, A. & Lemesre, J. L. (2001). Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrobial Agents and Chemotherapy, 45, 2064–2069.
   PubMed Web of Science ®Google Scholar
• Squires, K. E., Rosenkaimer, F., Sherwood, J. A., Forni, A. L., Were, J. B. & Murray, H. W. (1993). Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. American Journal of Tropical Medicine and Hygiene, 48, 666–669.
   PubMed Web of Science ®Google Scholar
• Sunder, S. (2001). Drug resistance in Indian visceral leishmaniasis. Tropical Medicine and International Health, 6, 849–854.
   PubMed Web of Science ®Google Scholar
• Sundar, S. & Murray, H. W. (1996). Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. Journal of Infectious Diseases, 173, 762–765.
   PubMed Web of Science ®Google Scholar
• Sundar, S., Rosenkaimer, F. & Murray, H. W. (1994). Successful treatment of refractory visceral leishmaniasis in India using antimony plus inter-feron gamma. Journal of Infectious Diseases, 170, 659–662.
   PubMed Web of Science ®Google Scholar
• Suschek, C. V., Bonmann, E., Kleinert, H. (2000). Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability. British Journal of Pharmacology, 131, 473–481.
   PubMed Web of Science ®Google Scholar
• Taylor, A. P. & Murray, H. W. (1998). Therapeutic effect of interferon-gamma gene transfer in experi-mental visceral leishmaniasis. Journal of Infectious Diseases, 178, 908–911.
   PubMed Web of Science ®Google Scholar
• Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T. & Tada, K. (1980). Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer, 26, 171–176.
   PubMed Web of Science ®Google Scholar
• World Health Organization (2000). Leishmaniasis and Leishmania/HIV Co-infection. Document WHO/ CDS/CSR/ISR/2000.1. Geneva: WHO.
   Google Scholar